Werfen is a growing, family-owned, innovative company founded in 1966 in Barcelona, Spain. In everything we do, we use our passion and long-term vision to develop meaningful innovations that truly enhance patient care and help create healthier societies worldwide.
We are a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Transfusion, Autoimmunity, and Transplant.
Our Hemostasis product portfolio comprises in vitro diagnostic systems, reagents, data management solutions, automation, and service, used to diagnose and guide treatment of thrombotic and bleeding disorders. Ultimately, Werfen's Hemostasis solutions improve the quality of patient care, lower costs, and assure regulatory compliance in the clinical laboratory.
From cardiovascular operating rooms and catheterization labs, to intensive care units and emergency departments, Werfen’s Acute Care Diagnostic solutions are integrated and comprehensive. This whole blood testing portfolio line helps clinicians and laboratorians save time, lower costs, assure regulatory compliance and improve patient outcomes.
